Michael Styler

1.1k total citations
61 papers, 609 citations indexed

About

Michael Styler is a scholar working on Oncology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Styler has authored 61 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 20 papers in Hematology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Styler's work include Acute Myeloid Leukemia Research (6 papers), Hemoglobinopathies and Related Disorders (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Michael Styler is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Hemoglobinopathies and Related Disorders (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Michael Styler collaborates with scholars based in United States, Australia and Philippines. Michael Styler's co-authors include Rasih Atilla Ener, David Topolsky, Pamela Crilley, Isadore Brodsky, Jun Teruya, Douglas E. Gladstone, Stephen I. Bulova, Terry Heiman‐Patterson, Marla S. Kaufman and Louis E. Samuels and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Michael Styler

55 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Styler United States 12 206 160 142 102 90 61 609
Linlin Cheng China 11 101 0.5× 66 0.4× 53 0.4× 96 0.9× 118 1.3× 46 628
Songxin Yan China 11 86 0.4× 62 0.4× 48 0.3× 97 1.0× 96 1.1× 34 593
M. Di Renzo Italy 17 74 0.4× 130 0.8× 90 0.6× 20 0.2× 122 1.4× 32 756
Tienan Zhu China 11 64 0.3× 163 1.0× 31 0.2× 64 0.6× 52 0.6× 55 576
Silvia Piantoni Italy 17 86 0.4× 73 0.5× 36 0.3× 81 0.8× 95 1.1× 58 967
René Cordtz Denmark 15 49 0.2× 145 0.9× 42 0.3× 74 0.7× 49 0.5× 48 763
Hélène Maillard France 14 27 0.1× 78 0.5× 68 0.5× 62 0.6× 74 0.8× 48 486
Liang-Tsai Hsiao Taiwan 15 260 1.3× 199 1.2× 45 0.3× 43 0.4× 400 4.4× 50 894
Maria Gabriella Raimondo Germany 13 81 0.4× 154 1.0× 17 0.1× 35 0.3× 63 0.7× 33 745
Chadi Saifan United States 13 87 0.4× 122 0.8× 41 0.3× 17 0.2× 71 0.8× 30 536

Countries citing papers authored by Michael Styler

Since Specialization
Citations

This map shows the geographic impact of Michael Styler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Styler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Styler more than expected).

Fields of papers citing papers by Michael Styler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Styler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Styler. The network helps show where Michael Styler may publish in the future.

Co-authorship network of co-authors of Michael Styler

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Styler. A scholar is included among the top collaborators of Michael Styler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Styler. Michael Styler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vartanov, Alexander R., Michele Sorrentino, Anne Ojala, et al.. (2024). Using Oral Vancomycin As Prophylaxis Against Clostridioides Difficile Infection in Stem Cell Transplant Recipients Is Associated with Increased Gram Negative Bacteremia. Transplantation and Cellular Therapy. 30(2). S440–S440.
2.
Styler, Michael, et al.. (2023). MM-595 Feasibility and Safety of Outpatient Model for Teclistamab Step-Up Dosing Administration: A Single Center Experience. Clinical Lymphoma Myeloma & Leukemia. 23. S509–S509. 2 indexed citations
3.
Şahin, Yavuz, Y. Lynn Wang, Jianming Pei, et al.. (2023). Multiple Genomic Alterations, Including a Novel AFF4::IRF1 Fusion Gene, in a Treatment-Refractory Blastic Plasmacytoid Dendritic-Cell Neoplasm: A Case Report and Literature Review. International Journal of Molecular Sciences. 25(1). 305–305. 3 indexed citations
4.
Styler, Michael, et al.. (2021). Angiosarcoma of the Face: A Case Study and Literature Review of Local and Metastatic Angiosarcoma. SHILAP Revista de lepidopterología. 2021. 1–5. 1 indexed citations
5.
Thadi, Anusha, Boris Polyak, Martin H. Bluth, et al.. (2020). Targeting Membrane HDM-2 by PNC-27 Induces Necrosis in Leukemia Cells But Not in Normal Hematopoietic Cells. Anticancer Research. 40(9). 4857–4867. 1 indexed citations
6.
L, Li, et al.. (2019). Case report of rhabdomyosarcomatous transformation of a primary gastrointestinal stromal tumor (GIST). BMC Cancer. 19(1). 913–913. 8 indexed citations
7.
Khan, Rabia, et al.. (2019). Optimization of inpatient chemotherapy administration utilizing evaluation intervals.. Journal of Clinical Oncology. 37(27_suppl). 75–75. 2 indexed citations
9.
Morano, William F., et al.. (2017). Complete Response after Treatment with Neoadjuvant Chemoradiation with Prolonged Chemotherapy for Locally Advanced, Unresectable Adenocarcinoma of the Pancreas. Case Reports in Oncological Medicine. 2017(1). 7834702–7834702. 6 indexed citations
10.
Crilley, Pamela, et al.. (2012). Evaluation of a Pretest Scoring System (4Ts) for the Diagnosis of Heparin-Induced Thrombocytopenia in a University Hospital Setting. Postgraduate Medicine. 124(6). 36–42. 12 indexed citations
11.
Grivas, Petros, et al.. (2008). Appendiceal Carcinoma: A Diagnostic and Therapeutic Challenge. Postgraduate Medicine. 120(4). 95–100. 7 indexed citations
12.
Schulman, Kevin A., Edward A. Stadtmauer, Shelby D. Reed, et al.. (2003). Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Bone Marrow Transplantation. 31(3). 205–210. 11 indexed citations
13.
Gladstone, Douglas E., Ann Alexis Prestrud, Michael Styler, et al.. (2002). High-dose cyclophosphamide for severe systemic lupus erythematosus. Lupus. 11(7). 405–410. 31 indexed citations
14.
Teruya, Jun, et al.. (2001). Questionable efficacy of plasma exchange for thrombotic thrombocytopenic purpura after bone marrow transplantation. Journal of Clinical Apheresis. 16(4). 169–174. 23 indexed citations
15.
Ener, Rasih Atilla, David Topolsky, Michael Styler, et al.. (2001). Use of Granulocyte Colony-Stimulating Factor After High-Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation. American Journal of Clinical Oncology. 24(1). 19–25. 6 indexed citations
16.
Teruya, Jun & Michael Styler. (2000). Management of factor XI inhibitor for cardiac intervention: successful treatment with immunosuppressive therapy and plasma exchange. Haemophilia. 6(3). 158–161. 19 indexed citations
18.
Samuels, Louis E., Marla S. Kaufman, Rohinton J. Morris, Michael Styler, & Stanley K. Brockman. (1999). Open heart surgery in patients with chronic lymphocytic leukemia. Leukemia Research. 23(1). 71–75. 38 indexed citations
19.
Rolston, David D.K., Stephen C. Rubin, David Topolsky, Michael Styler, & Pamela Crilley. (1998). Arterial Occlusions as a Presenting Feature of Acute Promyelocytic Leukemia. American Journal of Clinical Oncology. 21(5). 436–437. 15 indexed citations
20.
Abcar, Antoine, et al.. (1996). Splenectomy for Non-Hodgkin's Lymphoma. American Journal of Clinical Oncology. 19(6). 558–561. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026